Letter to the Editor: Finerenone and proteinuria in diabetic kidney disease
World Journal of Nephrology · 25.09.2026 · 15 (3)
DOI: 10.5527/wjn.121881 ↗Kurz gefasst
Leserbrief in der Zeitschrift World Journal of Nephrology, online erschienen am 25.09.2026. Verfasst von Vaia D Raikou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Doctors' General Clinic, Athens 11257, Greece. vraikou@med.uoa.gr. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Most patients with diabetic kidney disease (DKD) suffer from proteinuria. Finerenone, a novel nonsteroidal mineralocorticoid receptor antagonist acts as anti-inflammatory factor reducing the kidney inflammation and fibrotic pathways, which are overactive in patients with advanced proteinuria. The study by Pasari et al , published in the recent issue of the World Journal of Nephrology , correlated the greater reduction of albuminuria with the higher baseline albuminuria using finerenone. However, heterogeneity, disproportion and variability in response using finerenone for the reduction of proteinuria has been observed. Patients with persistent proteinuria despite the optimal renin-angiotensin-aldosterone system blockage, sodium-glucose co-transporter -2 inhibitors and finerenone, remain at high risk for renal and cardiovascular events. More factors including the novel functions of histone lactylation possibly are involved in the deterioration of albuminuria in DKD. It may need combined and intensive therapy with an additional healthy lifestyle. More pharmacogenomic trials, proteomic analyses in long-term real-world cohorts need to clarify the pathogenetic mechanisms related to proteinuria in DKD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Doctors' General Clinic, Athens 11257, Greece. vraikou@med.uoa.gr.
- Department of Weight-Surgery, Doctors' Hospital, Athens 11257, Greece.
Zitieren
APA
Raikou, V. D., & Gavriil, S. (2026). Letter to the Editor: Finerenone and proteinuria in diabetic kidney disease. World Journal of Nephrology, 15(3). https://doi.org/10.5527/wjn.121881
Vancouver
Raikou VD, Gavriil S. Letter to the Editor: Finerenone and proteinuria in diabetic kidney disease. World Journal of Nephrology. 2026;15(3). doi:10.5527/wjn.121881
BibTeX
@article{Raikou2026,
author = {Raikou, Vaia D and Gavriil, Sotiris},
title = {Letter to the Editor: Finerenone and proteinuria in diabetic kidney disease},
journal = {World Journal of Nephrology},
year = {2026},
volume = {15},
number = {3},
doi = {10.5527/wjn.121881}
}
EUVIMED